Clinical and sensorimotor gating effects of ketamine in normals.
about
Glutamatergic drugs for schizophreniaTo use or not to use: an update on licit and illicit ketamine useRealistic expectations of prepulse inhibition in translational models for schizophrenia research.Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.Chronic ketamine exposure induces permanent impairment of brain functions in adolescent cynomolgus monkeysEffects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategyCannabidiol Affects MK-801-Induced Changes in the PPI Learned Response of Capuchin Monkeys (Sapajus spp.).Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibitionEvidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibitionIs the acute NMDA receptor hypofunction a valid model of schizophrenia?Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population.Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.The effects of memantine on prepulse inhibition.Neurophysiological biomarkers for drug development in schizophrenia.Neurophysiological endophenotypes across bipolar and schizophrenia psychosis.Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.Exploring the impact of ketamine on the experience of illusory body ownershipKetamine perturbs perception of the flow of time in healthy volunteers.PACAP Protects Adult Neural Stem Cells from the Neurotoxic Effect of Ketamine Associated with Decreased Apoptosis, ER Stress and mTOR Pathway Activation.Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains.Do NMDA receptor antagonist models of schizophrenia predict the clinical efficacy of antipsychotic drugs?The effects of a subpsychotic dose of ketamine on recognition and source memory for agency: implications for pharmacological modelling of core symptoms of schizophrenia.Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI studyAnimal Models of Deficient Sensorimotor Gating in Schizophrenia: Are They Still Relevant?Startle Modification and P50 Gating in Schizophrenia Patients and Controls: Russian Population.Potential application as screening and drug designing tools of cytoarchitectural deficiencies present in three animal models of schizophrenia.Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.Effect of L-theanine on sensorimotor gating in healthy human subjects.Amphetamine effects on prepulse inhibition across-species: replication and parametric extension.Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition.Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats.Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice.Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.Chronic administration of ketamine mimics the perturbed sense of body ownership associated with schizophrenia.Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans.Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.
P2860
Q24246163-C8BAB661-8850-4257-9580-30A4E8B43E7AQ24634006-AABE98BB-C0D2-47F5-BC10-23E0DE4508F7Q24645703-3E5E70DA-1299-43EB-A696-D169DB58EAD5Q26830533-4EB2D69A-DCC0-454E-BA43-101264CEADACQ28082048-E1D2C4A9-4B7A-40E7-A692-5E0FB1DA8889Q28279105-DAC6A11D-B5B7-4E4C-A0B4-44C4EEE0F463Q30355399-C2DF43D8-5204-4397-A114-BCA1078EF58CQ30361241-A6452287-30B5-4B57-B482-915DBD342050Q30366961-B0703AAD-5ABB-4A56-B3F7-50716E1BE477Q30400548-AAC62144-5A4E-4529-88E3-CAB6F5733F3CQ30458275-C5C37621-F1F6-4067-81F0-F7CDF0C2A3EDQ30459655-11F7551C-8707-4E2F-B9F1-1D730B25B402Q30465425-F91B950B-5D4C-4F5A-8F57-FA4D29FC0FBEQ30474699-86184A07-43AB-4735-86A6-753C9585DB77Q30485038-F2019634-F42E-41F8-A02D-8DFC0D110C46Q30486447-C142B296-FCD7-4371-B470-4B4EA83CEA12Q30488646-E049B095-0DD0-41EF-BC13-774857B845C4Q30489404-E1322091-62D0-47B8-B99A-4A049978BADCQ34512497-450776BA-D1A0-49A0-BBEF-825303501851Q35534219-DE7DEED2-C0DB-4E84-A271-6E8124DEA088Q36261104-ECD53C09-31C9-4139-B4FF-D2D811F3B4A0Q36447398-D7F701CA-EC7D-47F6-8775-5BDD9C749E57Q36860053-09CA37DC-545B-43DB-9CE3-8C71B5666858Q37338722-121D60D4-7C1D-4963-A046-CB8C96E5D0B3Q37338763-C1BFE683-EBA2-47FB-BAC0-CB74DA791F59Q38852109-8D5200FF-3D41-43D2-9D8E-8026CD901007Q39952791-CB7CDBFF-E45A-4429-AEDE-C78D25A8E858Q39998926-8643254F-D1BD-449A-8DCA-C0702A9C9EE4Q42600971-9CF1A33E-5329-4A4D-9054-65C5AD1CFCC7Q43821608-95C396C8-FA2B-4FFF-A8FB-CE0B8E8CEB46Q44374761-8BC11D53-07E3-4906-A4A6-41BCD7455004Q44531014-E97CAB8D-4AAE-4D49-A4DF-5D8D6967C0D2Q45194999-01237D10-6C8F-4A56-BDC4-58A6BBF45472Q46785915-7F74778B-CBA7-48C0-9398-DC3C788AC2C0Q47746221-D9C4F3B9-EE5A-4C1B-A7EA-ED56FC186502Q47789466-81091336-5AD7-4B7A-A5B7-DE01D14A3F76Q48126400-B11F3CA1-CE6F-40E0-8C62-0BDD12CE2F1EQ48135115-1557C712-6393-4B34-B053-CDF31119D45AQ48316975-33DB91DF-519A-4097-934A-FC3F324DA916Q48587646-8E84E158-8073-4C2E-80F5-C01879E07CFF
P2860
Clinical and sensorimotor gating effects of ketamine in normals.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Clinical and sensorimotor gating effects of ketamine in normals.
@en
Clinical and sensorimotor gating effects of ketamine in normals.
@nl
type
label
Clinical and sensorimotor gating effects of ketamine in normals.
@en
Clinical and sensorimotor gating effects of ketamine in normals.
@nl
prefLabel
Clinical and sensorimotor gating effects of ketamine in normals.
@en
Clinical and sensorimotor gating effects of ketamine in normals.
@nl
P2093
P1476
Clinical and sensorimotor gating effects of ketamine in normals.
@en
P2093
E J Duncan
J P Rotrosen
M Stephanides
P B Chappell
S Chakravorty
S Gonzenbach
P356
10.1016/S0893-133X(00)00240-2
P407
P577
2001-07-01T00:00:00Z
P5875
P6179
1018021018